Loading clinical trials...
Loading clinical trials...
The primary aims of the HOME Study are to: * Design and implement a natural history study for metachromatic leukodystrophy to serve as a source of external control data, to augment or replace concurr...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
National Organization for Rare Disorders
Collaborators
NCT03047369 · Leukodystrophy, White Matter Disease, and more
NCT07046338 · Metachromatic Leukodystrophy (MLD)
NCT03725670 · Metachromatic Leukodystrophy (MLD)
NCT02171104 · Mucopolysaccharidosis Disorders, Hurler Syndrome, and more
NCT03392987 · Lysosomal Storage Disease, Metachromatic Leukodystrophy
National Organization for Rare Disorders
Danbury, Connecticut
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions